Critical evaluation of the role of acarbose in the treatment of diabetes: patient considerations.
about
The treatment of type 2 diabetes in the presence of renal impairment: what we should know about newer therapiesAcarbose: safe and effective for lowering postprandial hyperglycaemia and improving cardiovascular outcomesUpdate on the treatment of type 2 diabetes mellitusCombined use of basal insulin analog and acarbose reduces postprandial glucose in patients with uncontrolled type 2 diabetes.Acarbose improves glycemic control as add-on or monotherapy in Indian type-2 diabetes: Findings from the GlucoVIP multinational observational study.American Association of Clinical Endocrinologists' comprehensive diabetes management algorithm 2013 consensus statement--executive summary.Acarbose Decreases the Rheumatoid Arthritis Risk of Diabetic Patients and Attenuates the Incidence and Severity of Collagen-induced Arthritis in MiceUntapped diamonds for untamed diabetes: The α-glucosidase inhibitorsOn the potential of acarbose to reduce cardiovascular disease.Acarbose plus metformin fixed-dose combination in the management of type 2 diabetes.Pharmacological interventions for preventing or delaying onset of type 2 diabetes mellitus.Therapeutic potential of α-glucosidase inhibitors in type 2 diabetes mellitus: an evidence-based review.Improving postprandial hyperglycemia in patients with type 2 diabetes already on basal insulin therapy: Review of current strategies.Alpha-glucosidase inhibitors and risk of cancer in patients with diabetes mellitus: a systematic review and meta-analysis.Efficacy of acarbose in different geographical regions of the world: analysis of a real-life database.Lactobacillus strains isolated from infant faeces possess potent inhibitory activity against intestinal alpha- and beta-glucosidases suggesting anti-diabetic potential.Mulberry leaf extract reduces the glycemic indexes of four common dietary carbohydrates
P2860
Q26744317-8C88F704-1BB7-4A2D-91F2-7D30B75B0FADQ26778095-85156A5E-2EB5-431D-821C-AC9483FB0D4AQ28073342-63E99B22-3F91-41C8-BE26-FE466C6BF216Q33464541-A1AC6501-D551-4089-800F-CC7C5CC5E4A4Q33715376-21F0C40C-F576-4328-88E9-D47FAA05CD59Q34081331-11BE646F-C485-44A2-AA56-AA244FA9A4C4Q36382309-AC745062-3D60-444A-B21E-912E5EC618F3Q37703682-D7FD9BE4-04E6-4292-B3C1-91A42ADE22BFQ37717838-B1ACA23D-83CC-44AC-BD7E-FE2DECEFEE6DQ38223104-9C8A1B61-6D37-45E6-A15C-AFCCE1AFA9ADQ38259933-5F714E1A-4595-4D6D-AF7E-2850141A21B9Q38563239-D3D98FEB-8CF6-4C1A-8616-8780EC2AE29EQ39350860-1C047BF6-867A-4BC0-B1BB-54F46D578CBEQ45783993-71FE9782-4728-4387-815B-EA9CFFE4A317Q46783489-E790E1E2-0F69-4E17-8D0B-1FC5781B033FQ46947440-A5F75821-9F8D-4570-B6D2-5D920CAAC657Q58706329-DBB195E5-B49C-4DFD-ACAA-373EAE442FA2
P2860
Critical evaluation of the role of acarbose in the treatment of diabetes: patient considerations.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Critical evaluation of the rol ...... betes: patient considerations.
@ast
Critical evaluation of the rol ...... betes: patient considerations.
@en
type
label
Critical evaluation of the rol ...... betes: patient considerations.
@ast
Critical evaluation of the rol ...... betes: patient considerations.
@en
prefLabel
Critical evaluation of the rol ...... betes: patient considerations.
@ast
Critical evaluation of the rol ...... betes: patient considerations.
@en
P2860
P356
P1476
Critical evaluation of the rol ...... betes: patient considerations.
@en
P2093
Christoph Rosak
Gabriele Mertes
P2860
P304
P356
10.2147/DMSO.S28340
P577
2012-10-12T00:00:00Z